Partner with key customers and stimulate business growth by offering strategic pricing opportunities and customized business plans. Champion aesthetic products, implement sales programs, improve customer acquisition and retention, and optimize practice workflow for better customer experiences. Strong sales professional skilled in Medical Devices, Biotechnology, Healthcare, and Business Intelligence.

Principal business consultant leading strategic sales and marketing efforts that grows business and increases footprint in designated region. Expand usage of product portfolio by cultivating close relationships with top-tier customers.

As Director of Operations, achieved Company’s first profit in 2nd year of business; established health benefits and 401 K in third year; established and funded Company’s first profit share program to employees in 5th year; grew gross revenue from $150k annual sales to $3.6 million. Rebranded Company to "Ocean Drive" and was awarded two registered US trademarks. Directed buildout of 9,000 sq foot medspa that has been featured in New Beauty Magazine, MedEsthetics Magazine, and Vero Beach Portfolio. Assessed competitive landscape of plastic surgery and aesthetic markets in local area. Defined company's points of distinction and trained staff on messaging, branding, and customer service. Managed Company's online reputation through development of engaging social media posts on multiple FB pages, IG accounts, and multiple websites. Developed Company's websites including customized CSS style sheets and managed SEO and analytics. Established new service line in Dermatology.Founded an advanced medical training center, that included the design and buildout of training rooms and the educational program. Established a distributorship with a global retail skincare company.

Assisted start-up businesses with presentations and proposals to pitch to angel investors. Advised technology start-ups with business planning, website development, and social media.

Technology Scout, leading transfer of intellectual property for client companies. As matchmaker, provide vital connections between strategic partners searching for leading-edge technologies and the public and private laboratories creating them. Manage expert consultants, data presentation and deliverables. Partner with C-level executives to define technologies for new product development and to define and strategize growth/re-direction through technology-acquisition opportunities. Perform market, financial and intellectual-property analysis. Negotiate licensing agreements, royalty programs, material transfer agreements, R&D contracts, confidentiality agreements and consulting agreements for private and public companies based in the US and abroad.

Published Doctoral Dissertation, "The Nuclear Export of DNA Topoisomerase IIa as a Mechanism of Drug Resistance in Hematological Malignancies".Published Engel, R., et al., Experimental Cell Research 2004,(295), 421-431.Published Engel, R., et al., J. Cell Science 2004, (117), 361-3071.

Recruited to serve as Medical Science Liaison (one of 12 such positions nationally) supporting marketing, sales and training for the Company's high-end genetic and esoteric testing services in the hospital market for Southeastern US region. Provided CME credits and spoke as the Keynote Speaker at medical conferences and University-based Hospital Grand Rounds to educate healthcare providers on the latest genetic testing guidelines. Championed the latest molecular diagnostic tests and established rapport with key opinion leaders, enabling Quest Diagnostics to meet and/or exceed financial targets.

Conducted and published independent research; promoted findings through presentations at national and international scientific meetings. Designed and conducted experiments; supervised undergraduate students with lab work and projects.Studied mechanisms of drug resistance in hematological cancers; identified novel mechanism in vitro and correlated findings to observations in clinical trials. Resulted in transformation of clinical protocol for treatment of patients with multiple myeloma.Procured $100,000+ Micromanipulator for research project. Conducted extensive, in-depth research, compiled information and presented convincing, multi-dimensional proposition to C-level executives, with emphasis on cost-effectiveness and reputational advantages to Moffitt. Micromanipulator became central to a new Core Technology Facility, placing Moffitt on the cutting edge of research in Florida.